Printer Friendly
The Free Library
14,550,259 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Bio-Tech Israel 2005 Exhibitor Profiles.


TEL AVIV Tel Aviv (tĕl əvēv`), city (1994 pop. 355,200), W central Israel, on the Mediterranean Sea. Oficially named Tel Aviv–Jaffa, it is Israel's commercial, financial, communications, and cultural center and the core of its largest , Israel Israel, in the Bible
Israel (ĭz`rēəl, ĭz`rāəl) [as understood by Hebrews,=he strives with God], according to the book of Genesis, name given to Jacob as eponymous ancestor of the Hebrews, the chosen people of God.
 -- Bio-Tech Israel 2005 takes place May 24-26 at the David Intercontinental in·ter·con·ti·nen·tal  
adj.
1. Extending or taking place between or among continents: intercontinental exploration; intercontinental cooperation.

2.
 Hotel in Tel Aviv. For in-depth in-depth
adj.
Detailed; thorough: an in-depth study.


in-depth
Adjective

detailed or thorough: an in-depth analysis

 information about the event visit www.kenes.com/biotech.

Below are profiles from Bio-Tech Israel 2005 exhibitors; breaking news releases are available at http://www.tradeshownews.com, Business Wire's trade show, conference, and event news resource.

Business Wire is the official news wire service for Bio-Tech Israel 2005.
Company: Experimental Pathology Laboratories, Inc
    Booth/Stand: 80
    Media Contact: Dr. Jerry Hardisty
    Phone: 919/998-9407
    E-mail: jhardisty@epl-inc.com
    Web: www.epl-inc.com

    Company description: Experimental Pathology Laboratories (EPL(R))
provides contract histology and toxicologic pathology support in two
laboratories in the United States near Washington, DC, and in North
Carolina. Our pathology services are provided by 25 experienced
veterinary pathologists, most certified by the American College of
Veterinary Pathologists. Technical and clerical staffs trained in
reporting pathology data support these pathologists. EPL's histology
laboratories are staffed by highly qualified technicians, including
certified Histologic Technicians. Our laboratories produce microscope
slides from more than 50,000 tissues per month. Among other services
offered are immunohistochemistry and digital morphometry. EPL operates
in full compliance with U.S. and International GLPs.

    Company: Flexiprobe
    Booth/Stand: 50
    Media Contact: Nili Tamir
    Phone: 972-3-5312600
    E-mail: info@radbiomed.com
    Web: www.radbiomed.com

    Product description: Flexible intravaginal probe for treating
urinary incontinence
    Company description: Development of an electrical stimulation and
biofeedback device for the ambulatory treatment of female urinary
incontinence.
    The device consists of intravaginal probe which electrically
stimulates and strengthens the pelvic floor muscles.

    Company: MaimoniDex RA
    Booth/Stand: 50
    Media Contact: Nili Tamir
    Phone: 972-3-5312600
    E-mail: igolan@radbiomed.com
    Web: www.radbiomed.com

    Product description: Monoclonal antibodies for treating Rheumatoid
Arthritis
    Company description: Treating Rheumatoid Arthritis with disease
specific anti CD-44 monoclonal antibody. The CD44 molecule and its
splice variants provide new opportunities for the discovery of
specific therapies for cancer and inflammatory diseases.

    Company: NatSpears
    Booth/Stand: 50
    Media Contact: Nili Tamir
    Phone: 972-3-5312600
    E-mail: Eyal_fima@natspears.com
    Web: www.radbiomed.com

    Product description: Selective human proteins for treating cancer
and viral infections
    Company description: NatSpears products are novel molecules
capable of:
    Binding selectively to a broad spectrum of tumor cells and virus
    infected cells. Inducing killing via natural mechanisms of the
    immune system.
    Being used as therapeutic compounds by themselves or as a platform
    to improve the efficacy and safety of chemotherapeutic agents.

    Company: Patheon Inc.
    Booth/Stand: 15
    Ticker Symbol & Exchange: PTI: TSX
    Media Contact: Kevin McCarthy
    Investor Relations Contact: Shelley Jourard
    Phone: 1-905-821-4001
    E-mail: patheon@patheon.com
    Web: http://www.patheon.com

    Product description: Patheon offers analytical,
pre-formulation/formulation development through to commercial
manufacturing services, for virtually all dosage forms, including
prescription (Rx) and consumer (OTC) products. Our expertise includes
specialized capabilities such as cephalosporin, high-potency, and
sterile manufacturing, including aseptic filling and lyophilization.
    Company description: Patheon is a leading provider of drug
development and manufacturing services to the international
pharmaceutical industry. Operating a network of 14 facilities in the
United States, Canada and Europe, Patheon employs over 5,700 people
and serves a client base of more than 180 pharmaceutical and
biotechnology companies.

    Company: Proterec
    Booth/Stand: 50
    Media Contact: Nili Tamir
    Phone: 972-3-5312600
    E-mail: alaban@proterec.com
    Web: www.radbiomed.com

    Product description: Novel biocatalysts
    Company description: Proterec has developed a patented
state-of-the-art recombinant technology for the generation of
synthetic enzymes of supreme capabilities to serve as biocatalysts in
key reactions of various industrial processes. The advantage of the
technology lies in its ability to overcome the limitations of DNA
shuffling.

    Company: Rad BioMed
    Booth/Stand: 50
    Media Contact: Nili Tamir
    Phone: 972-3-5312600
    E-mail: info@radbiomed.com
    Web: www.radbiomed.com

    Company description: RAD BIOMED INCUBATOR LTD. is a life-science
incubator for medical device and biotechnology start-ups. The
incubator provides an initial home and seed capital, medical and
technical support and access to private and capital funds.
COPYRIGHT 2005 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:May 19, 2005
Words:649
Previous Article:Synplicity Announces Stock Repurchase Program of up to One Million Shares of Its Common Stock over Next 12 Months.
Next Article:Hummingbird and Omtool Announce AccuRoute Integration with LegalKEY Records Management.



Related Articles
Rainforest Renaissance.
Cultivating biotech trees.(Brief Article)
Int. Data Group unit launches Bio-IT Research initiative for Asia/Pacific.(Brief Article)
Biotechnology is Not Affected by the Situation; 80 Percent of the Participants in the Biotech 2002 Week Have Already Reserved a Place At Biotech 2003.
Biotechnology Industry Gearing Up for Bio-Tech Israel 2004 Conference and Exhibition.
Novartis, Johnson & Johnson, Merck, Teva, among Leading Pharmaceutical and Biotechnology Firms to Appear During Biotechnology Week at Bio-Tech Israel...
10 Promising Biotech Projects Reach the Final Stage of Rad BioMed's Outstanding Project Competition.
Trade mission builds on life sciences industry.(Provincial Update)
IDG sells Bio-IT World, Inc. to Cambridge Healthtech Institute.
EuroBiO 2007 and Business Wire Sign a Partnership Agreement.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles